On Monday evening, AstraZeneca announced the launch of a €1.4 billion bond issue in two tranches, designed to finance the company's general corporate purposes.

The biopharmaceutical group states that the issue comprises a fixed-rate tranche of €650 million with a coupon of 3.121%, maturing in 2030.

A further tranche of 750 million euros, maturing in 2033, again at a fixed rate, was issued with a coupon of 3.278%.

BNP Paribas, Goldman Sachs, Morgan Stanley and Société Générale were responsible for managing the order book.

AstraZeneca shares were down 1.7% in early morning trading.

Copyright (c) 2024 CercleFinance.com. All rights reserved.